78 - Pharmacokinetics

Moderator(s)

• 

  Lisa Dumkow, Pharm D., BCIDP (she/her/hers)

  Infectious Disease Clinical Pharmacist
  Trinity Health Grand Rapids
  Grand Rapids, MI, United States
• 

  Alexander Lepak, MD, FIDSA

  Associate Professor
  University of Wisconsin
  Madison, WI, United States

Presentations:

• 1:45 PM – 1:57 PM US ET

  Pharmacokinetic Estimation Analysis of Multi-Dose Regimens of Dalbavancin for Treatment of Osteomyelitis or Bacteremia
  

  Presenting Author: Cecilia Volk, PharmD (she/her/hers) – University of Wisconsin-Madison

  Co-Author: Paul Hutson, PharmD, MS – University of Wisconsin- Madison, School of Pharmacy

  Co-Author: Warren Rose, PharmD, MPH – University of Wisconsin-Madison
• 1:57 PM – 2:09 PM US ET

  Imipenem-Cilastatin-Relebactam (I/R) Pharmacokinetics (PK) in Critically Ill Patients Supported on Extracorporeal Membrane Oxygenation (ECMO)
  

  Presenting Author: Andrew J. Fratoni, PharmD – Hartford Hospital

  Co-Author: Abigail Kois, PharmD – Hartford Hospital

  Co-Author: Jason A. Gluck, DO, FACC – Hartford Hospital

  Co-Author: David P. Nicolau, PharmD – Hartford Hospital

  Co-Author: Joseph L. Kuti, PharmD – Hartford Hospital
• 2:09 PM – 2:21 PM US ET

  Pharmacokinetic/Pharmacodynamic Evaluation and Dose Optimization of Daptomycin in Pediatric Patients with Staphylococcus aureus Bacteremia
  

  Presenting Author: Katie B. Olney, PharmD, BCIDP (she/her/hers) – University of Kentucky HealthCare

  Co-Author: Joel I. Howard, MD – University of Kentucky HealthCare

  Co-Author: David Burgess, PharmD, FCCP, FIDP – UK HealthCare
• 2:21 PM – 2:33 PM US ET

  Real World Experience of Posaconazole Therapeutic Drug Monitoring in Oncology Patients: Clinical Implications of Hypoalbuminemia as a Predictor of Subtherapeutic Posaconazole Levels
  

  Presenting Author: Yanina Pasikhova, PharmD – Moffitt Cancer Center

  Co-Author: John Greene, MD – Moffitt Cancer Center

  Co-Author: Austin R. Morrison, PharmD – Moffitt Cancer Center

  Co-Author: Guy Handley, MD – University of South Florida
• 2:33 PM – 2:45 PM US ET

  Age and Body Mass Index Impact Optimal Vancomycin Model Selection for Bayesian Dosing: Results from a Large Multi-site Retrospective Study of Adult Patients
  

  Presenting Author: Maria-Stephanie Hughes, PharmD (she/her/hers) – InsightRX

  Co-Author: Tiffany Lee, PharmD – InsightRX
• 2:45 PM – 2:57 PM US ET

  Population Pharmacokinetic/Pharmacodynamic (PK/PD) Target Attainment Analysis of Intravenous Fosfomycin for Treatment of Multidrug-Resistant Gram-Negative Bacterial Infections
  

  Presenting Author: Walaiporn Wangchinda, MD – University of Michigan College of Pharmacy

  Co-Author: jason M. Pogue, PharmD – University of Michigan, College of Pharmacy

  Co-Author: Visanu Thamlikitkul, MD – Faculty of Medicine Siriraj Hospital, Mahidol University

  Co-Author: Pannee Leelawattanachai, PharmD, BCP – Navamindradhiraj University

  Co-Author: Pornpan Koomanachai, MD – Faculty of Medicine Siriraj Hospital, Mahidol University

  Co-Author: Manjunath (Amit) Pai, PharmD – Clinical Pharmacy, University of Michigan